Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-Dioxino[2,3-f]quinoxaline
AssigneeWyeth
InventorsJonathan L. Gross, Gary P. Stack
Life of this patent
Estimating the term…
Abstract
Compounds of the formula: are useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
Claims1
A method of treating a subject suffering from a condition selected from the group consisting of obesity, anorexia nervosa, bulimia nervosa, vasomotor flushing, alcohol addiction, and premature ejaculation, which comprises providing to the subject suffering from said condition, a therapeutically effective amount of a compound of formula I
- wherein
- R1, R4, R5, R6 and R8 are, independently, hydrogen, hydroxy, halo, cyano, carboxamido, carboalkoxy of two to six carbon atoms, trifluoromethyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkanoyloxy of 2 to 6 carbon atoms, amino mono- or di-alkylamino in which each alkyl group has 1 to 6 carbon atoms alkanamido of 2 to 6 carbon atoms, or alkanesulfonamido of 1 to 6 carbon atoms;
- R2 and R3 are, independently, hydrogen, alkyl of 1 to 6 carbon atoms, halogen, hydroxy, cyano or amino;
- R7 is hydrogen or alkyl of 1 to 6 carbon atoms;
- the dotted line represents an optional double bond;
- Z is CR8 or N;
- and
- n is an integer 0, 1 or 2;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.